Related Experiment Video
Updated: Mar 9, 2026
05:36
Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane
Published on: February 8, 2020
9.6K
[c-MET Oncogene in Renal Cell Carcinomas]
F Erlmeier1, W Weichert1, M Autenrieth2
1Institut für Pathologie, Technische Universität München.
Aktuelle Urologie
|December 23, 2016
Summary
The c-Met tyrosine kinase is a prognostic marker in some renal cell carcinomas and a potential target for personalized medicine. Its role in other renal tumor subtypes requires further investigation.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- c-Met, a proto-oncogene-encoded tyrosine kinase, influences cellular processes like tumor invasiveness and metastasis.
- c-Met expression is linked to clinical outcomes and prognosis in certain renal cell carcinoma (RCC) subtypes, establishing it as a prognostic marker.
- The precise role of c-Met across all RCC subtypes remains incompletely understood.
Purpose of the Study:
- To explore the prognostic significance of c-Met in renal cell carcinoma.
- To investigate the potential of c-Met as a therapeutic target in personalized medicine for RCC.
- To clarify the role of c-Met in renal tumor subtypes where its relevance is yet to be determined.
Main Methods:
- Literature review and analysis of existing studies on c-Met expression in renal cell carcinoma.
- Examination of c-Met's role in tumor behavior, including invasiveness and metastasis.
- Evaluation of c-Met's potential in targeted therapy, particularly dual inhibition of VEGF and c-MET.
Main Results:
- c-Met is confirmed as a prognostic marker in specific subtypes of renal cell carcinoma.
- Dual inhibition of VEGF and c-MET tyrosine kinase shows increasing clinical relevance for metastatic, treatment-resistant RCC.
- The function and prognostic value of c-Met in other renal tumor subtypes are not yet fully elucidated.
Conclusions:
- c-Met is a significant prognostic marker for certain renal cell carcinomas.
- Targeting c-Met, especially in combination with VEGF inhibition, is a promising strategy for advanced, refractory RCC.
- Further research is needed to fully understand c-Met's role in all subtypes of renal cell carcinoma and other renal tumors.
More Related Videos
Related Concept Videos
03:03mTOR Signaling and Cancer Progression
5.0K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
5.0K
02:38Mitogens and the Cell Cycle
8.3K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.3K
02:30Metastasis
6.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.7K
01:20The Retinoblastoma Gene
4.9K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.9K
02:23Abnormal Proliferation
5.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
01:06Induced Pluripotent Stem Cells
5.8K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
5.8K